The Ecstasy and Agony of Assay Interference Compounds.
作者信息
Aldrich Courtney, Bertozzi Carolyn, Georg Gunda I, Kiessling Laura, Lindsley Craig, Liotta Dennis, Merz Kenneth M, Schepartz Alanna, Wang Shaomeng
机构信息
ACS Infectious Diseases.
ACS Central Science.
出版信息
ACS Med Chem Lett. 2017 Feb 28;8(4):379-382. doi: 10.1021/acsmedchemlett.7b00056. eCollection 2017 Apr 13.
Abstract
摘要
相似文献
1
The Ecstasy and Agony of Assay Interference Compounds.分析干扰化合物的喜与忧
ACS Med Chem Lett. 2017 Feb 28;8(4):379-382. doi: 10.1021/acsmedchemlett.7b00056. eCollection 2017 Apr 13.
2
Eroticism in group psychotherapy: psychoanalytic reflections on desire, agony, and ecstasy.团体心理治疗中的色情内容：对欲望、痛苦与狂喜的精神分析思考
Int J Group Psychother. 2003 Oct;53(4):443-57. doi: 10.1521/ijgp.53.4.443.42831.
3
Comment on The Ecstasy and Agony of Assay Interference Compounds.评分析干扰化合物的喜与忧
J Chem Inf Model. 2017 Nov 27;57(11):2640-2645. doi: 10.1021/acs.jcim.7b00313. Epub 2017 Nov 7.
4
The Ecstasy and Agony of Assay Interference Compounds.分析干扰化合物的狂喜与痛苦
ACS Cent Sci. 2017 Mar 22;3(3):143-147. doi: 10.1021/acscentsci.7b00069. Epub 2017 Feb 28.
5
The Ecstasy and Agony of Assay Interference Compounds.分析干扰化合物的喜与忧
ACS Infect Dis. 2017 Apr 14;3(4):259-262. doi: 10.1021/acsinfecdis.7b00023. Epub 2017 Feb 28.
6
The Ecstasy and Agony of Assay Interference Compounds.分析干扰化合物的喜与忧
ACS Chem Biol. 2017 Mar 17;12(3):575-578. doi: 10.1021/acschembio.7b00119. Epub 2017 Feb 28.
7
The Ecstasy and Agony of Assay Interference Compounds.分析干扰化合物的喜与忧
Biochemistry. 2017 Mar 14;56(10):1363-1366. doi: 10.1021/acs.biochem.7b00110. Epub 2017 Feb 28.
8
The Ecstasy and Agony of Assay Interference Compounds.分析干扰化合物的喜与忧
ACS Chem Neurosci. 2017 Mar 15;8(3):420-423. doi: 10.1021/acschemneuro.7b00064. Epub 2017 Feb 28.
9
The Ecstasy and Agony of Assay Interference Compounds.分析干扰化合物的喜与忧
J Chem Inf Model. 2017 Mar 27;57(3):387-390. doi: 10.1021/acs.jcim.7b00105. Epub 2017 Feb 28.
10
The Ecstasy and Agony of Assay Interference Compounds.分析干扰化合物的喜与忧
J Med Chem. 2017 Mar 23;60(6):2165-2168. doi: 10.1021/acs.jmedchem.7b00229. Epub 2017 Feb 28.
引用本文的文献
1
How Should we Teach Medicinal Chemistry in Higher Education to Prepare Students for a Future Career as Medicinal Chemists and Drug Designers? - A Teacher's Perspective.在高等教育中，我们应如何教授药物化学，以使学生为未来成为药物化学家和药物设计师做好准备？——一位教师的视角
ChemMedChem. 2025 Jan 14;20(2):e202400791. doi: 10.1002/cmdc.202400791. Epub 2024 Nov 20.
2
Preclinical Studies and Drug Combination of Low-Cost Molecules for Chagas Disease.恰加斯病低成本分子的临床前研究与药物联合应用
Pharmaceuticals (Basel). 2022 Dec 23;16(1):20. doi: 10.3390/ph16010020.
3
Dual Targeting of MDM4 and FTH1 by MMRi71 for Induced Protein Degradation and p53-Independent Apoptosis in Leukemia Cells.MMRi71 通过双重靶向 MDM4 和 FTH1 诱导白血病细胞发生蛋白降解和 p53 非依赖型细胞凋亡。
Molecules. 2022 Nov 8;27(22):7665. doi: 10.3390/molecules27227665.
4
Covalent sortase A inhibitor ML346 prevents infection of .共价分选酶A抑制剂ML346可预防……的感染。 （原文中“infection of.”后面内容缺失）
RSC Med Chem. 2021 Nov 1;13(2):138-149. doi: 10.1039/d1md00316j. eCollection 2022 Feb 23.
5
6
1,2-Naphthoquinone-4-sulfonic acid salts in organic synthesis.1,2-萘醌-4-磺酸盐在有机合成中的应用。
Beilstein J Org Chem. 2022 Jan 5;18:53-69. doi: 10.3762/bjoc.18.5. eCollection 2022.
7
Inhibitors of HIV-1 Nef-Mediated Activation of the Myeloid Src-Family Kinase Hck Block HIV-1 Replication in Macrophages and Disrupt MHC-I Downregulation.HIV-1 Nef 介导的髓样Src 家族激酶 Hck 激活抑制剂阻断巨噬细胞中的 HIV-1 复制并破坏 MHC-I 下调。
ACS Infect Dis. 2022 Jan 14;8(1):91-105. doi: 10.1021/acsinfecdis.1c00288. Epub 2022 Jan 5.
8
A Dual-Specificity Inhibitor Targets Polyphosphate Kinase 1 and 2 Enzymes To Attenuate Virulence of Pseudomonas aeruginosa.双重特异性抑制剂靶向多聚磷酸盐激酶 1 和 2 酶以减轻铜绿假单胞菌的毒力。
mBio. 2021 Jun 29;12(3):e0059221. doi: 10.1128/mBio.00592-21. Epub 2021 Jun 15.
9
Novel Immune Modulators Enhance Resistance to Multiple Pathogens.新型免疫调节剂增强对多种病原体的抵抗力。
mSphere. 2021 Jan 6;6(1):e00950-20. doi: 10.1128/mSphere.00950-20.
10
Chemoinformatic Database Building and in Silico Hit-Identification of Potential Multi-Targeting Bioactive Compounds Extracted from Mushroom Species.化学信息数据库构建及从蘑菇物种中提取的潜在多靶点生物活性化合物的计算机虚拟命中鉴定
Molecules. 2017 Sep 19;22(9):1571. doi: 10.3390/molecules22091571.
本文引用的文献
1
Discovery of a Selective Aurora A Kinase Inhibitor by Virtual Screening.通过虚拟筛选发现一种选择性极光激酶A抑制剂。
J Med Chem. 2016 Aug 11;59(15):7188-211. doi: 10.1021/acs.jmedchem.6b00709. Epub 2016 Jul 20.
2
Badapple: promiscuity patterns from noisy evidence.《坏苹果：来自嘈杂证据的滥交模式》
J Cheminform. 2016 May 28;8:29. doi: 10.1186/s13321-016-0137-3. eCollection 2016.
3
Feeling Nature's PAINS: Natural Products, Natural Product Drugs, and Pan Assay Interference Compounds (PAINS).感受大自然的“痛点”：天然产物、天然产物药物与泛分析干扰化合物（PAINS）
J Nat Prod. 2016 Mar 25;79(3):616-28. doi: 10.1021/acs.jnatprod.5b00947. Epub 2016 Feb 22.
4
Can Invalid Bioactives Undermine Natural Product-Based Drug Discovery?无效生物活性成分会破坏基于天然产物的药物发现吗？
J Med Chem. 2016 Mar 10;59(5):1671-90. doi: 10.1021/acs.jmedchem.5b01009. Epub 2015 Oct 27.
5
How to Triage PAINS-Full Research.如何对PAINS-Full研究进行分诊。
Assay Drug Dev Technol. 2016 Apr;14(3):168-74. doi: 10.1089/adt.2015.674. Epub 2015 Oct 23.
6
Docking studies on the interaction of flavonoids with fat mass and obesity associated protein.黄酮类化合物与脂肪量和肥胖相关蛋白相互作用的对接研究
Pak J Pharm Sci. 2015 Sep;28(5):1647-53.
7
Pan Assay Interference Compounds (PAINS) and Other Promiscuous Compounds in Antifungal Research.抗真菌研究中的泛分析干扰化合物（PAINS）及其他混杂化合物
J Med Chem. 2016 Jan 28;59(2):497-503. doi: 10.1021/acs.jmedchem.5b00361. Epub 2015 Sep 8.
8
An Aggregation Advisor for Ligand Discovery.用于配体发现的聚集顾问程序。
J Med Chem. 2015 Sep 10;58(17):7076-87. doi: 10.1021/acs.jmedchem.5b01105. Epub 2015 Aug 28.
9
The promise and peril of chemical probes.化学探针的前景与风险
Nat Chem Biol. 2015 Aug;11(8):536-41. doi: 10.1038/nchembio.1867.
10
Novel Broad Spectrum Inhibitors Targeting the Flavivirus Methyltransferase.靶向黄病毒甲基转移酶的新型广谱抑制剂
PLoS One. 2015 Jun 22;10(6):e0130062. doi: 10.1371/journal.pone.0130062. eCollection 2015.
Zotero 插件